Brad Schmidt

Co-Founder & CEO | Panaxium

Brad is the Co-founder and CEO of Panaxium, a startup focused on developing precision neuromodulation therapies to dramatically improve recovery from stroke & traumatic brain injury. Brad is an experienced startup CEO, leading medical imaging & analytical instrument startups. As a management consultant with McKinsey & Company, he served Fortune 500 companies in the Retail, Transportation, and Energy industries. Dr. Schmidt holds BSc, MEng, and PhD degrees, all from Cornell University.